APO RESEARCH · REPORT
Medical Second Opinion
Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward surge in medical second opinion services mainly due to financial, health and legal costs involved in the treatment. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.
Product & engineering
Understand the product.
Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward surge in medical second opinion services mainly due to financial, health and legal costs involved in the treatment. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.
Selected research
Industry Growth & Trends
Global Medical Second Opinion Industry Growth and Trends Forecast to 2032
Market perspective
Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward surge in medical second opinion services mainly due to financial, health and legal costs involved in the treatment. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.
According to APO Research, the global Medical Second Opinion market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Medical Second Opinion market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Medical Second Opinion market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Medical Second Opinion market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Medical Second Opinion.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Medical Second Opinion market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Medical Second Opinion Market by Company
HCA Hospitals
AXA PPP Healthcare
Royal London Group
Helsana Group
Cleveland Clinic
Amradnet
Best Doctors Inc
Inova Care
Toranomon Hospital
Keio University Hospital
Johns Hopkins Medicine
Penn Medicine
Oncology International Pvt. Ltd.
GrandOpinion
London Pain Clinic
Mondial Assistance
Medisense
Medo Asia Sdn. Bhd.
Medical Second Opinion Segment by Type
Hospitals
Medical Second Opinion Providing Companies
Health Insurance Companies
Medical Second Opinion Segment by Application
Cancer
Diabetes
Cardiac Disorders
Neurological Disorders
Ocular Disorders
Others
Medical Second Opinion Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Second Opinion market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Second Opinion and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Second Opinion.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Medical Second Opinion companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Hospitals
- Medical Second Opinion Providing Companies
- Health Insurance Companies
Applications
- Cancer
- Diabetes
- Cardiac Disorders
- Neurological Disorders
- Ocular Disorders
- Others
Companies covered
- HCA Hospitals
- AXA PPP Healthcare
- Royal London Group
- Helsana Group
- Cleveland Clinic
- Amradnet
- Best Doctors Inc
- Inova Care
- Toranomon Hospital
- Keio University Hospital
- Johns Hopkins Medicine
- Penn Medicine
- Oncology International Pvt. Ltd.
- GrandOpinion
- London Pain Clinic
- Mondial Assistance
- Medisense
- Medo Asia Sdn. Bhd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Medical Second Opinion Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Medical Second Opinion Market Size by Region (2021-2032)
- 1.4.1 Global Medical Second Opinion Market Size by Region (2021-2026)
- 1.4.2 Global Medical Second Opinion Market Size by Region (2027-2032)
- 1.5 Key Regions Medical Second Opinion Market Size (2021-2032)
- 1.5.1 North America Medical Second Opinion Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Medical Second Opinion Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Medical Second Opinion Market Size Growth Rate (2021-2032)
- 1.5.4 South America Medical Second Opinion Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Medical Second Opinion Market Size Growth Rate (2021-2032)
2 Medical Second Opinion Market by Type
- 2.1 Type Introduction
- 2.1.1 Hospitals
- 2.1.2 Medical Second Opinion Providing Companies
- 2.1.3 Health Insurance Companies
- 2.2 Global Medical Second Opinion Market Size by Type
- 2.2.1 Global Medical Second Opinion Market Size Overview by Type (2021-2032)
- 2.2.2 Global Medical Second Opinion Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Medical Second Opinion Market Size Forecasted by Type (2027-2032)
- 2.3 Global Medical Second Opinion Market Size by Regions
- 2.3.1 North America Medical Second Opinion Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Medical Second Opinion Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Medical Second Opinion Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Medical Second Opinion Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Medical Second Opinion Market Size Breakdown by Type (2021-2026)
3 Medical Second Opinion Market by Application
- 3.1 Type Introduction
- 3.1.1 Cancer
- 3.1.2 Diabetes
- 3.1.3 Cardiac Disorders
- 3.1.4 Neurological Disorders
- 3.1.5 Ocular Disorders
- 3.1.6 Others
- 3.2 Global Medical Second Opinion Market Size by Application
- 3.2.1 Global Medical Second Opinion Market Size Overview by Application (2021-2032)
- 3.2.2 Global Medical Second Opinion Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Medical Second Opinion Market Size Forecasted by Application (2027-2032)
- 3.3 Global Medical Second Opinion Market Size by Regions
- 3.3.1 North America Medical Second Opinion Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Medical Second Opinion Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Medical Second Opinion Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Medical Second Opinion Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Medical Second Opinion Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Medical Second Opinion Industry Trends
- 4.2 Medical Second Opinion Industry Drivers
- 4.3 Medical Second Opinion Industry Opportunities and Challenges
- 4.4 Medical Second Opinion Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Medical Second Opinion Revenue (2021-2026)
- 5.2 Global Medical Second Opinion Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Medical Second Opinion Key Company Headquarters & Area Served
- 5.4 Global Medical Second Opinion Company, Product Type & Application
- 5.5 Global Medical Second Opinion Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Medical Second Opinion Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Medical Second Opinion Players Market Share by Revenue in 2025
- 5.6.3 2025 Medical Second Opinion Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 HCA Hospitals
- 6.1.1 HCA Hospitals Company Information
- 6.1.2 HCA Hospitals Business Overview
- 6.1.3 HCA Hospitals Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 HCA Hospitals Medical Second Opinion Product Portfolio
- 6.1.5 HCA Hospitals Recent Developments
- 6.2 AXA PPP Healthcare
- 6.2.1 AXA PPP Healthcare Company Information
- 6.2.2 AXA PPP Healthcare Business Overview
- 6.2.3 AXA PPP Healthcare Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 AXA PPP Healthcare Medical Second Opinion Product Portfolio
- 6.2.5 AXA PPP Healthcare Recent Developments
- 6.3 Royal London Group
- 6.3.1 Royal London Group Company Information
- 6.3.2 Royal London Group Business Overview
- 6.3.3 Royal London Group Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Royal London Group Medical Second Opinion Product Portfolio
- 6.3.5 Royal London Group Recent Developments
- 6.4 Helsana Group
- 6.4.1 Helsana Group Company Information
- 6.4.2 Helsana Group Business Overview
- 6.4.3 Helsana Group Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Helsana Group Medical Second Opinion Product Portfolio
- 6.4.5 Helsana Group Recent Developments
- 6.5 Cleveland Clinic
- 6.5.1 Cleveland Clinic Company Information
- 6.5.2 Cleveland Clinic Business Overview
- 6.5.3 Cleveland Clinic Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Cleveland Clinic Medical Second Opinion Product Portfolio
- 6.5.5 Cleveland Clinic Recent Developments
- 6.6 Amradnet
- 6.6.1 Amradnet Company Information
- 6.6.2 Amradnet Business Overview
- 6.6.3 Amradnet Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Amradnet Medical Second Opinion Product Portfolio
- 6.6.5 Amradnet Recent Developments
- 6.7 Best Doctors Inc
- 6.7.1 Best Doctors Inc Company Information
- 6.7.2 Best Doctors Inc Business Overview
- 6.7.3 Best Doctors Inc Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Best Doctors Inc Medical Second Opinion Product Portfolio
- 6.7.5 Best Doctors Inc Recent Developments
- 6.8 Inova Care
- 6.8.1 Inova Care Company Information
- 6.8.2 Inova Care Business Overview
- 6.8.3 Inova Care Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Inova Care Medical Second Opinion Product Portfolio
- 6.8.5 Inova Care Recent Developments
- 6.9 Toranomon Hospital
- 6.9.1 Toranomon Hospital Company Information
- 6.9.2 Toranomon Hospital Business Overview
- 6.9.3 Toranomon Hospital Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Toranomon Hospital Medical Second Opinion Product Portfolio
- 6.9.5 Toranomon Hospital Recent Developments
- 6.10 Keio University Hospital
- 6.10.1 Keio University Hospital Company Information
- 6.10.2 Keio University Hospital Business Overview
- 6.10.3 Keio University Hospital Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Keio University Hospital Medical Second Opinion Product Portfolio
- 6.10.5 Keio University Hospital Recent Developments
- 6.11 Johns Hopkins Medicine
- 6.11.1 Johns Hopkins Medicine Company Information
- 6.11.2 Johns Hopkins Medicine Business Overview
- 6.11.3 Johns Hopkins Medicine Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Johns Hopkins Medicine Medical Second Opinion Product Portfolio
- 6.11.5 Johns Hopkins Medicine Recent Developments
- 6.12 Penn Medicine
- 6.12.1 Penn Medicine Company Information
- 6.12.2 Penn Medicine Business Overview
- 6.12.3 Penn Medicine Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Penn Medicine Medical Second Opinion Product Portfolio
- 6.12.5 Penn Medicine Recent Developments
- 6.13 Oncology International Pvt. Ltd.
- 6.13.1 Oncology International Pvt. Ltd. Company Information
- 6.13.2 Oncology International Pvt. Ltd. Business Overview
- 6.13.3 Oncology International Pvt. Ltd. Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Oncology International Pvt. Ltd. Medical Second Opinion Product Portfolio
- 6.13.5 Oncology International Pvt. Ltd. Recent Developments
- 6.14 GrandOpinion
- 6.14.1 GrandOpinion Company Information
- 6.14.2 GrandOpinion Business Overview
- 6.14.3 GrandOpinion Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 GrandOpinion Medical Second Opinion Product Portfolio
- 6.14.5 GrandOpinion Recent Developments
- 6.15 London Pain Clinic
- 6.15.1 London Pain Clinic Company Information
- 6.15.2 London Pain Clinic Business Overview
- 6.15.3 London Pain Clinic Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 London Pain Clinic Medical Second Opinion Product Portfolio
- 6.15.5 London Pain Clinic Recent Developments
- 6.16 Mondial Assistance
- 6.16.1 Mondial Assistance Company Information
- 6.16.2 Mondial Assistance Business Overview
- 6.16.3 Mondial Assistance Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Mondial Assistance Medical Second Opinion Product Portfolio
- 6.16.5 Mondial Assistance Recent Developments
- 6.17 Medisense
- 6.17.1 Medisense Company Information
- 6.17.2 Medisense Business Overview
- 6.17.3 Medisense Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Medisense Medical Second Opinion Product Portfolio
- 6.17.5 Medisense Recent Developments
- 6.18 Medo Asia Sdn. Bhd.
- 6.18.1 Medo Asia Sdn. Bhd. Company Information
- 6.18.2 Medo Asia Sdn. Bhd. Business Overview
- 6.18.3 Medo Asia Sdn. Bhd. Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Medo Asia Sdn. Bhd. Medical Second Opinion Product Portfolio
- 6.18.5 Medo Asia Sdn. Bhd. Recent Developments
7 North America
- 7.1 North America Medical Second Opinion Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Medical Second Opinion Market Size by Country (2021-2026)
- 7.3 North America Medical Second Opinion Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Medical Second Opinion Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Medical Second Opinion Market Size by Country (2021-2026)
- 8.3 Europe Medical Second Opinion Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Medical Second Opinion Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Medical Second Opinion Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Medical Second Opinion Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Medical Second Opinion Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Medical Second Opinion Market Size by Country (2021-2026)
- 10.3 South America Medical Second Opinion Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Medical Second Opinion Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Medical Second Opinion Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Medical Second Opinion Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst